Cargando…
Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study
BACKGROUND: Biological sex, gender and age have an impact on the incidence and outcome in patients with metastatic pancreatic cancer. The aim of this study is to investigate whether biological sex, gender and age are associated with treatment allocation and overall survival (OS) of patients with met...
Autores principales: | Pijnappel, Esther N., Schuurman, Melinda, Wagner, Anna D., de Vos-Geelen, Judith, van der Geest, Lydia G. M., de Groot, Jan-Willem B., Koerkamp, Bas Groot, de Hingh, Ignace H. J. T., Homs, Marjolein Y. V., Creemers, Geert-Jan, Cirkel, Geert A., van Santvoort, Hjalmar C., Busch, Olivier R., Besselink, Marc G., van Eijck, Casper H.J., Wilmink, Johanna W., van Laarhoven, Hanneke W. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987273/ https://www.ncbi.nlm.nih.gov/pubmed/35402271 http://dx.doi.org/10.3389/fonc.2022.839779 |
Ejemplares similares
-
The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population‐based analysis
por: Bakens, Maikel J., et al.
Publicado: (2016) -
Chyle Leak After Pancreatoduodenectomy: Clinical Impact and Risk Factors in a Nationwide Analysis
por: Augustinus, Simone, et al.
Publicado: (2023) -
Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022) -
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Janssen, Quisette P., et al.
Publicado: (2021) -
Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model
por: Latenstein, Anouk E. J., et al.
Publicado: (2020)